{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:42:08Z","timestamp":1790404928973,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07438","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T11:15:30Z","timestamp":1418296530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity"],"prefix":"10.1038","volume":"4","author":[{"given":"F.","family":"Ratzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Haslacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Poeppl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Steinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Burgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. F.","family":"Pickl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. G.","family":"Schmetterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"BFsrep07438_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00228-011-1161-x","volume":"68","author":"P Zarogoulidis","year":"2012","unstructured":"Zarogoulidis, P. et al. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol 68, 479\u2013503 (2012).","journal-title":"Eur J Clin Pharmacol"},{"key":"BFsrep07438_CR2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/bph.12574","volume":"171","author":"V Balloy","year":"2014","unstructured":"Balloy, V. et al. Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge. Br J Pharmacol. 171, 1783\u20131794 (2014).","journal-title":"Br J Pharmacol."},{"key":"BFsrep07438_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nrmicro1265","volume":"3","author":"J Poehlsgaard","year":"2005","unstructured":"Poehlsgaard, J. & Douthwaite, S. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3, 870\u2013881 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFsrep07438_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.idc.2009.06.013","volume":"23","author":"JM Zuckerman","year":"2009","unstructured":"Zuckerman, J. M., Qamar, F. & Bono, B. R. Macrolides, ketolides and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline. Infect Dis Clin North Am. 23, 997\u20131026 (2009).","journal-title":"Infect Dis Clin North Am."},{"key":"BFsrep07438_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0924-8579(01)00430-7","volume":"18","author":"WL Hand","year":"2001","unstructured":"Hand, W. L. & Hand, D. L. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. Int. J. Antimicrob. Agents 18, 419\u2013425 (2001).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFsrep07438_CR6","doi-asserted-by":"publisher","first-page":"584262","DOI":"10.1155\/2012\/584262","volume":"2012","author":"HC Steel","year":"2012","unstructured":"Steel, H. C., Theron, A. J., Cockeran, R., Anderson, R. & Feldman, C. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm. 2012, 584262 (2012).","journal-title":"Mediators Inflamm."},{"key":"BFsrep07438_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1128\/AAC.40.1.75","volume":"40","author":"A Wildfeuer","year":"1996","unstructured":"Wildfeuer, A., Laufen, H. & Zimmermann, T. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother. 40, 75\u201379 (1996).","journal-title":"Antimicrob Agents Chemother."},{"key":"BFsrep07438_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1179\/joc.1997.9.1.23","volume":"9","author":"A Fietta","year":"1997","unstructured":"Fietta, A., Merlini, C. & Gialdroni Grassi, G. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. J Chemother 9, 23\u201331 (1997).","journal-title":"J Chemother"},{"key":"BFsrep07438_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00044011-199815020-00009","volume":"15","author":"CH Ballow","year":"1998","unstructured":"Ballow, C. H., Amsden, G. W., Highet, V. S. & Forrest, A. Pharmacokinetics of Oral Azithromycin in Serum, Urine, Polymorphonuclear Leucocytes and Inflammatory vs Non-Inflammatory Skin Blisters in Healthy Volunteers. Clin Drug Investig. 15, 159\u2013167 (1998).","journal-title":"Clin Drug Investig."},{"key":"BFsrep07438_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jac\/47.1.61","volume":"47","author":"GW Amsden","year":"2001","unstructured":"Amsden, G. W. & Gray, C. L. Serum and WBC pharmacokinetics of 1500\u2005mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. J Antimicrob Chemother. 47, 61\u201366 (2001).","journal-title":"J Antimicrob Chemother."},{"key":"BFsrep07438_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert, R. K. et al. Azithromycin for Prevention of Exacerbations of COPD. N Engl J Med. 365, 689\u2013698 (2011).","journal-title":"N Engl J Med."},{"key":"BFsrep07438_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.rmed.2012.12.019","volume":"107","author":"S Simoens","year":"2013","unstructured":"Simoens, S., Laekeman, G. & Decramer, M. Preventing COPD exacerbations with macrolides: A review and budget impact analysis. Respir. Med. 107, 637\u2013648 (2013).","journal-title":"Respir. Med."},{"key":"BFsrep07438_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/thorax.57.3.212","volume":"57","author":"J Wolter","year":"2002","unstructured":"Wolter, J. et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 57, 212\u2013216 (2002).","journal-title":"Thorax"},{"key":"BFsrep07438_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jac\/dkh309","volume":"54","author":"MJ Schultz","year":"2004","unstructured":"Schultz, M. J. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother. 54, 21\u201328 (2004).","journal-title":"J Antimicrob Chemother."},{"key":"BFsrep07438_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong, C. et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 380, 660\u2013667 (2012).","journal-title":"Lancet"},{"key":"BFsrep07438_CR16","first-page":"Cd007716","volume":"2","author":"M Yang","year":"2013","unstructured":"Yang, M. et al. Macrolides for diffuse panbronchiolitis. The Cochrane database of systematic reviews 2, Cd007716 (2013).","journal-title":"The Cochrane database of systematic reviews"},{"key":"BFsrep07438_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","volume":"85","author":"J Gottlieb","year":"2008","unstructured":"Gottlieb, J. et al. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 85, 36\u201341 (2008).","journal-title":"Transplantation."},{"key":"BFsrep07438_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/bmt.2009.106","volume":"44","author":"N Maimon","year":"2009","unstructured":"Maimon, N., Lipton, J. H., Chan, C. K. N. & Marras, T. K. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients. Bone Marrow Transplant. 44, 69\u201373 (2009).","journal-title":"Bone Marrow Transplant."},{"key":"BFsrep07438_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","volume":"68","author":"GG Brusselle","year":"2013","unstructured":"Brusselle, G. G. et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. 68, 322\u2013329 (2013).","journal-title":"Thorax."},{"key":"BFsrep07438_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","volume":"177","author":"JL Simpson","year":"2008","unstructured":"Simpson, J. L., Powell, H., Boyle, M. J., Scott, R. J. & Gibson, P. G. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 177, 148\u2013155 (2008).","journal-title":"Am J Respir Crit Care Med."},{"key":"BFsrep07438_CR21","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1378\/chest.125.2_suppl.52S","volume":"125","author":"MH Gotfried","year":"2004","unstructured":"Gotfried, M. H. Macrolides for the treatment of chronic sinusitis, asthma and COPD. Chest 125, 52S\u201361S (2004).","journal-title":"Chest"},{"key":"BFsrep07438_CR22","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.ijantimicag.2010.11.008","volume":"36","author":"SM Opal","year":"2010","unstructured":"Opal, S. M. New perspectives on immunomodulatory therapy for bacteraemia and sepsis. Int J Antimicrob Agents. 36, S70\u2013S73 (2010).","journal-title":"Int J Antimicrob Agents."},{"key":"BFsrep07438_CR23","unstructured":"National Guideline, C. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health and the HIV Medicine Association of the Infectious Diseases Society of America, 2013 URL: http:\/\/www.guideline.gov\/content.aspx?id=45359 (accessed: 09.09.2014)"},{"key":"BFsrep07438_CR24","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/j.2042-7158.2011.01343.x","volume":"63","author":"Y Hiwatashi","year":"2011","unstructured":"Hiwatashi, Y. et al. Azithromycin suppresses proliferation, interleukin production and mitogen-activated protein kinases in human peripheral-blood mononuclear cells stimulated with bacterial superantigen. J Pharm Pharmacol 63, 1320\u20131326 (2011).","journal-title":"J Pharm Pharmacol"},{"key":"BFsrep07438_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1179\/joc.2009.21.4.396","volume":"21","author":"S Ikegaya","year":"2009","unstructured":"Ikegaya, S., Inai, K., Iwasaki, H., Naiki, H. & Ueda, T. Azithromycin reduces tumor necrosis factor-alpha production in lipopolysaccharide-stimulated THP-1 monocytic cells by modification of stress response and p38 MAPK pathway. J Chemother 21, 396\u2013402 (2009).","journal-title":"J Chemother"},{"key":"BFsrep07438_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0924-8579(98)00091-0","volume":"11","author":"AA Khan","year":"1999","unstructured":"Khan, A. A., Slifer, T. R., Araujo, F. G. & Remington, J. S. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents. 11, 121\u2013132 (1999).","journal-title":"Int J Antimicrob Agents."},{"key":"BFsrep07438_CR27","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1476-5381.2011.01576.x","volume":"165","author":"M Vrancic","year":"2012","unstructured":"Vrancic, M. et al. Azithromycin distinctively modulates classical activation of human monocytes in vitro. Br J Pharmacol. 165, 1348\u20131360 (2012).","journal-title":"Br J Pharmacol."},{"key":"BFsrep07438_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.intimp.2010.12.010","volume":"11","author":"M Bosnar","year":"2011","unstructured":"Bosnar, M. et al. Azithromycin inhibits macrophage interleukin-1 beta production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia. Int Immunopharmacol. 11, 424\u2013434 (2011).","journal-title":"Int Immunopharmacol."},{"key":"BFsrep07438_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1600-6143.2006.01586.x","volume":"7","author":"BM Vanaudenaerde","year":"2007","unstructured":"Vanaudenaerde, B. M. et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 7, 76\u201382 (2007).","journal-title":"Am J Transplant"},{"key":"BFsrep07438_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijantimicag.2004.10.009","volume":"25","author":"J-I Kadota","year":"2005","unstructured":"Kadota, J.-I. et al. Antibiotic-induced apoptosis in human activated peripheral lymphocytes. Int J Antimicrob Agents 25, 216\u2013220 (2005).","journal-title":"Int J Antimicrob Agents"},{"key":"BFsrep07438_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijantimicag.2004.03.022","volume":"24","author":"Y Ishimatsu","year":"2004","unstructured":"Ishimatsu, Y. et al. Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro. Int J Antimicrob Agents 24, 247\u2013253 (2004).","journal-title":"Int J Antimicrob Agents"},{"key":"BFsrep07438_CR32","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.intimp.2004.05.011","volume":"4","author":"S Mizunoe","year":"2004","unstructured":"Mizunoe, S. et al. Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol 4, 1201\u20131207 (2004).","journal-title":"Int Immunopharmacol"},{"key":"BFsrep07438_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.smim.2007.02.008","volume":"19","author":"A Mondino","year":"2007","unstructured":"Mondino, A. & Mueller, D. L. mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol. 19, 162\u2013172 (2007).","journal-title":"Semin Immunol."},{"key":"BFsrep07438_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i4.20","volume":"21","author":"YJ Bi","year":"2011","unstructured":"Bi, Y. J., Liu, G. W. & Yang, R. F. mTOR Regulates T-Cell Differentiation and Activation in Immunity and Autoimmunity. Crit. Rev. Eukaryot. Gene Expr. 21, 313\u2013322 (2011).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"BFsrep07438_CR35","first-page":"viii61","volume":"22","author":"C Morath","year":"2007","unstructured":"Morath, C. et al. Sirolimus in renal transplantation. Nephrol Dial Transplant 22 Suppl 8viii61\u2013viii65 (2007).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep07438_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/01.ftd.0000245377.93401.39","volume":"28","author":"I Buhaescu","year":"2006","unstructured":"Buhaescu, I., Izzedine, H. & Covic, A. Sirolimus - Challenging current perspectives. Ther. Drug Monit. 28, 577\u2013584 (2006).","journal-title":"Ther. Drug Monit."},{"key":"BFsrep07438_CR37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1126\/science.1067710","volume":"295","author":"KH Lee","year":"2002","unstructured":"Lee, K. H. et al. T cell receptor signaling precedes immunological synapse formation. Science 295, 1539\u20131542 (2002).","journal-title":"Science"},{"key":"BFsrep07438_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/TP.0b013e318276a19f","volume":"95","author":"A Egli","year":"2013","unstructured":"Egli, A., Kumar, D., Broscheit, C., O'Shea, D. & Humar, A. Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. Transplantation. 95, 448\u2013455 (2013).","journal-title":"Transplantation."},{"key":"BFsrep07438_CR39","first-page":"324","volume":"27","author":"WU Kim","year":"2000","unstructured":"Kim, W. U. et al. Divergent effect of cyclosporine on Th1\/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis. J Rheumatol. 27, 324\u2013331 (2000).","journal-title":"J Rheumatol."},{"key":"BFsrep07438_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trim.2010.03.004","volume":"23","author":"K Kawamoto","year":"2010","unstructured":"Kawamoto, K., Pahuja, A., Hering, B. J. & Bansal-Pakala, P. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs. Transpl Immunol. 23, 28\u201333 (2010).","journal-title":"Transpl Immunol."},{"key":"BFsrep07438_CR41","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/jac\/dki251","volume":"56","author":"AC Williams","year":"2005","unstructured":"Williams, A. C., Galley, H. F., Watt, A. M. & Webster, N. R. Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother. 56, 502\u2013506 (2005).","journal-title":"J Antimicrob Chemother."},{"key":"BFsrep07438_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1399-0012.2011.01420.x","volume":"26","author":"GS Dhillon","year":"2012","unstructured":"Dhillon, G. S. et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. Clin. Transplant. 26, 105\u2013110 (2012).","journal-title":"Clin. Transplant."},{"key":"BFsrep07438_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jaci.2010.07.024","volume":"126","author":"ER Sutherland","year":"2010","unstructured":"Sutherland, E. R. et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol. 126, 747\u2013753 (2010).","journal-title":"J Allergy Clin Immunol."},{"key":"BFsrep07438_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","volume":"99","author":"D Banerjee","year":"2005","unstructured":"Banerjee, D., Khair, O. A. & Honeybourne, D. The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. Respir. Med. 99, 208\u2013215 (2005).","journal-title":"Respir. Med."},{"key":"BFsrep07438_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/0003088-200948010-00002","volume":"48","author":"M Zeitlitzger","year":"2009","unstructured":"Zeitlitzger, M., Waper, C. C. & Heinisch, B. Ketolides - The Modern Relatives of Macrolides The Pharmacokinetic Perspective. Clin Pharmacokinet 48, 23\u201338 (2009).","journal-title":"Clin Pharmacokinet"},{"key":"BFsrep07438_CR46","first-page":"88","volume":"32","author":"M Cazzola","year":"1994","unstructured":"Cazzola, M. et al. Evaluation of lung tissue and hilar lymph node concentrations of azithromycin. Int J Clin Pharmacol Ther. 32, 88\u201391 (1994).","journal-title":"Int J Clin Pharmacol Ther."},{"key":"BFsrep07438_CR47","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1128\/AAC.41.6.1399","volume":"41","author":"KA Rodvold","year":"1997","unstructured":"Rodvold, K. A., Gotfried, M. H., Danziger, L. H. & Servi, R. J. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother. 41, 1399\u20131402 (1997).","journal-title":"Antimicrob Agents Chemother."},{"key":"BFsrep07438_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jac\/47.1.61","volume":"47","author":"GW Amsden","year":"2001","unstructured":"Amsden, G. W. & Gray, C. L. Serum and WBC pharmacokinetics of 1500\u2005mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. J Antimicrob Chemother. 47, 61\u201366 (2001).","journal-title":"J Antimicrob Chemother."},{"key":"BFsrep07438_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1128\/AAC.00852-06","volume":"51","author":"P Liu","year":"2007","unstructured":"Liu, P. et al. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. Antimicrob Agents Chemother. 51, 103\u2013109 (2007).","journal-title":"Antimicrob Agents Chemother."},{"key":"BFsrep07438_CR50","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1128\/AAC.02011-12","volume":"57","author":"P Matzneller","year":"2013","unstructured":"Matzneller, P. et al. Blood, Tissue and Intracellular Concentrations of Azithromycin during and after End of Therapy. Antimicrob Agents Chemother. 57, 1736\u20131742 (2013).","journal-title":"Antimicrob Agents Chemother."},{"key":"BFsrep07438_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1183\/09031936.00089407","volume":"34","author":"R Stamatiou","year":"2009","unstructured":"Stamatiou, R. et al. Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells. Eur Respir J. 34, 721\u2013730 (2009).","journal-title":"Eur Respir J."},{"key":"BFsrep07438_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/ja.2009.125","volume":"63","author":"R Stamatiou","year":"2010","unstructured":"Stamatiou, R., Boukas, K., Paraskeva, E., Molyvdas, P. A. & Hatziefthimiou, A. Azithromycin reduces the viability of human bronchial smooth muscle cells. J Antibiot 63, 71\u201375 (2010).","journal-title":"J Antibiot"},{"key":"BFsrep07438_CR53","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1476-5381.2008.00102.x","volume":"156","author":"WQ Chen","year":"2009","unstructured":"Chen, W. Q. et al. Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels. Br J Pharmacol. 156, 941\u2013951 (2009).","journal-title":"Br J Pharmacol."},{"key":"BFsrep07438_CR54","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1476-5381.2008.00080.x","volume":"156","author":"L Zhao","year":"2009","unstructured":"Zhao, L. et al. Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. Br J Pharmacol. 156, 774\u2013785 (2009).","journal-title":"Br J Pharmacol."},{"key":"BFsrep07438_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/glia.22433","volume":"61","author":"C Dello Russo","year":"2013","unstructured":"Dello Russo, C., Lisi, L., Feinstein, D. L. & Navarra, P. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. 61, 301\u2013311 (2013).","journal-title":"Glia."},{"key":"BFsrep07438_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.transproceed.2013.10.040","volume":"46","author":"YM Liu","year":"2014","unstructured":"Liu, Y. M., Shao, Y. Q. & He, Q. Sirolimus for treatment of autosomal-dominant polycystic kidney disease: a meta-analysis of randomized controlled trials. Transplant Proc. 46, 66\u201374 (2014).","journal-title":"Transplant Proc."},{"key":"BFsrep07438_CR57","first-page":"Cd007191","volume":"4","author":"MMB Uthman","year":"2013","unstructured":"Uthman, M. M. B., Uthman, O. A. & Yahaya, I. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database Syst Rev. 4, Cd007191 (2013).","journal-title":"Cochrane Database Syst Rev."},{"key":"BFsrep07438_CR58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00042560-200208010-00008","volume":"30","author":"GR Seage","year":"2002","unstructured":"Seage, G. R. et al. The relationship of preventable opportunistic infections, HIV-1 RNA and CD4 cell counts to chronic mortality. J. Acquir. Immune Defic. Syndr. 30, 421\u2013428 (2002).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFsrep07438_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ejim.2012.04.016","volume":"23","author":"JM Pereira","year":"2012","unstructured":"Pereira, J. M., Paiva, J. A. & Rello, J. Severe sepsis in community-acquired pneumonia - Early recognition and treatment. Eur. J. Intern. Med. 23, 412\u2013419 (2012).","journal-title":"Eur. J. Intern. Med."},{"key":"BFsrep07438_CR60","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.ijantimicag.2008.06.004","volume":"32","author":"EJ Giamarellos-Bourboulis","year":"2008","unstructured":"Giamarellos-Bourboulis, E. J. Immunomodulatory therapies for sepsis: unexpected effects with macrolides. Int J Antimicrob Agents. 32, S39\u2013S43 (2008).","journal-title":"Int J Antimicrob Agents."},{"key":"BFsrep07438_CR61","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/CCM.0b013e318274645f","volume":"41","author":"S Inoue","year":"2013","unstructured":"Inoue, S. et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med. 41, 810\u2013819 (2013).","journal-title":"Crit Care Med."},{"key":"BFsrep07438_CR62","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer, J. S. et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306, 2594\u20132605 (2011).","journal-title":"JAMA"},{"key":"BFsrep07438_CR63","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0006-291X(03)01482-7","volume":"308","author":"G Roth","year":"2003","unstructured":"Roth, G. et al. Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun. 308, 840\u2013846 (2003).","journal-title":"Biochem Biophys Res Commun."},{"key":"BFsrep07438_CR64","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/cc7875","volume":"13","author":"R Osawa","year":"2009","unstructured":"Osawa, R. & Singh, N. Cytomegalovirus infection in critically ill patients: a systematic review. Critical Care. 13, R68 (2009).","journal-title":"Critical Care."},{"key":"BFsrep07438_CR65","doi-asserted-by":"publisher","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton, A. H. et al. Reactivation of multiple viruses in patients with sepsis. PloS One. 9, e98819 (2014).","journal-title":"PloS One."},{"key":"BFsrep07438_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaci.2010.10.023","volume":"127","author":"KG Schmetterer","year":"2011","unstructured":"Schmetterer, K. G. et al. Bet v 1-specific T-cell receptor\/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner. J Allergy Clin Immunol. 127, 238\u2013245, 245.e231\u2013233 (2011).","journal-title":"J Allergy Clin Immunol."},{"key":"BFsrep07438_CR67","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1098\/rspb.2005.3432","volume":"273","author":"B Asquith","year":"2006","unstructured":"Asquith, B. et al. Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci. 273, 1165\u20131171 (2006).","journal-title":"Proc Biol Sci."},{"key":"BFsrep07438_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2010.09.020","volume":"362","author":"J Leitner","year":"2010","unstructured":"Leitner, J. et al. T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells. J Immunol Methods. 362, 131\u2013141 (2010).","journal-title":"J Immunol Methods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07438","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T06:12:30Z","timestamp":1672985550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep07438"],"URL":"https:\/\/doi.org\/10.1038\/srep07438","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]},"assertion":[{"value":"17 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7438"}}